The patent, issued in Australia, is based on systems and methods for
enhancing muscle fiber formation to develop high-quality
meat
REHOVOT, Israel, June 9, 2022
/PRNewswire/ -- MeaTech 3D Ltd. (Nasdaq: MITC) ("MeaTech"), an
international deep-tech food company at the forefront of the
cultured meat industry, is pleased to announce that it has received
its first patent out of several that are currently pending. The
patent, granted by IP Australia, is based on the company's
development of systems and methods to apply external forces to
muscle tissue that result in the development of high-quality
complex structured meat.
One of the main challenges of producing structured meat is to
enable the muscle tissue to mature with an enhanced fibrous texture
that results in a mouthfeel with the right elasticity, density and
taste. "Our patented systems and methods strengthen and enhance
cultured muscle tissues in a way that mimics how a cow's muscles
are developed while it walks and grazes," said Dan Kozlovski, MeaTech's Chief Technology
Officer.
Arik Kaufman, MeaTech's Chief
Executive Officer: "We are excited about the first patent
approval of our novel technology and processes. This achievement
strengthens the company's IP which we believe will help speed up
MeaTech's entry into the market as the leading producer of
high-quality cultivated whole cuts of meat. We will also provide
technology and services to third-party food-sector players."
View our patent here:
https://patentimages.storage.googleapis.com/bb/59/88/62caca3feb01a7/AU2020349580A1.pdf
About MeaTech
MeaTech is an international deep-tech
food company at the forefront of the cultured meat revolution. The
company initiated activities in 2019 and is listed on the Nasdaq
Capital Market under the ticker "MITC". MeaTech maintains
facilities in Rehovot, Israel and
Antwerp, Belgium and is in the
process of expanding activities to the US. The company believes
cultivated meat technologies hold significant potential to improve
meat production, simplify the meat supply chain, and offer
consumers a range of new product offerings.
MeaTech aims to provide an alternative to industrialized animal
farming that dramatically reduces carbon footprint, minimizes water
and land usage, and prevents the slaughtering of animals. With a
modular factory design, MeaTech aims to offer a
sustainable solution for producing a variety of beef, chicken
and pork products, both as raw materials and whole cuts.
For more information, please visit:
https://meatech3d.com
Forward-Looking Statements
This press release contains forward-looking statements
concerning MeaTech's business, operations and financial performance
and condition as well as plans, objectives, and expectations for
MeaTech's business operations and financial performance and
condition. Any statements that are not historical facts may be
deemed to be forward-looking statements. Forward-looking statements
reflect MeaTech's current views with respect to future events and
are based on assumptions and subject to known and unknown risks and
uncertainties, which change over time, and other factors that may
cause MeaTech's actual results, performance or achievements to be
materially different from any future results, performance or
achievements expressed or implied by the forward-looking
statements. Forward-looking statements include, without limitation,
any statement that may predict, forecast, indicate or imply future
results, performance or achievements, and are typically identified
with words such as "may," "could," "should," "will," "would,"
"believe," "anticipate," "estimate," "expect," "aim," "intend,"
"plan" or words or phases of similar meaning and include, without
limitation, MeaTech's expectations regarding the success of its
cultured meat manufacturing technologies it is developing, which
will require significant additional work before MeaTech can
potentially launch commercial sales; MeaTech's research and
development activities associated with technologies for cultured
meat manufacturing, including three-dimensional meat production,
which involves a lengthy and complex process; MeaTech's ability to
obtain and enforce its intellectual property rights and to operate
its business without infringing, misappropriating, or otherwise
violating the intellectual property rights and proprietary
technology of third parties; and other risks and uncertainties,
including those identified in MeaTech's Annual Report on Form 20-F
for the fiscal year ended December 31,
2021, filed with the Securities and Exchange Commission on
March 24, 2022. New risks and
uncertainties may emerge from time to time, and it is not possible
for MeaTech to predict their occurrence or how they will affect
MeaTech. If one or more of the factors affecting MeaTech's
forward-looking information and statements proves incorrect, then
MeaTech's actual results, performance or achievements could differ
materially from those expressed in, or implied by, forward-looking
information and statements contained in this press release.
Therefore, MeaTech cautions you not to place undue reliance on its
forward-looking information and statements. MeaTech disclaims any
duty to revise or update the forward-looking statements, whether
written or oral, to reflect actual results or changes in the
factors affecting the forward-looking statements, except as
specifically required by law.
MeaTech Press
Contact:
|
MeaTech Investor
Contacts:
|
|
Maissa
Dauriac
Rainier Communications
mdauriac@rainierco.com
|
Joseph Green
Edison Group
jgreen@edisongroup.com
|
Ehud Helft
Edison Israel
ehelft@edisongroup.com
|
Logo:
https://mma.prnewswire.com/media/1753830/MeaTech_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/meatech-granted-patent-for-physical-manipulation-of-cultured-muscle-tissue-301564945.html
SOURCE MeaTech 3D Ltd.